课题基金 / 基金详情

Genetic labeling and visualization of CSMN in models of motor neuron disorders

Genetic labeling and visualization of CSMN in models of motor neuron disorders
运动神经元疾病模型中 CSMN 的基因标记和可视化
批准号:
8731290
负责人:
Pembe Hande Ozdinler
金额:
$19.12万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-15 至 2016-08-31

项目摘要

项目成果

Pembe Hande Ozdinler的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):在我们的大脑皮层中有数千种不同的神经元群体,但在神经退行性疾病中,只有选定的神经元群体表现出初级脆弱性并经历进行性退化。皮质脊髓运动神经元(CSMN)是位于运动皮质V层的大锥体神经元。它们的细胞结构非常独特,它们充当大脑皮层启动和调节运动的“轮辐人”。自愿行动是聪明和见多识广的头脑的行为。因此,CSMN从许多神经元接收信息,包括长距离投射神经元和局部回路神经元。CSMN将这些信息整合并翻译成一个信号并发送给脊髓靶点的独特能力,使其有别于其他皮质神经元。因此,它的退化具有严重的后果,导致各种运动障碍。了解CSMN变性在疾病中的基础是一种发展中的需要。然而,CSMN的识别和可视化并不容易,因为它们嵌入在大脑皮层内数以千计的其他神经元群体中。我们最近创造了一个新的报告系,UCHL1-EGFP小鼠,其中CSMN在运动皮质中进行遗传标记。在UCHL1启动子的控制下,EGFP在体内的表达稳定,持续到P800,并且仅限于运动皮质中的CSMN。通过解剖、逆行标记、分子标志物表达谱和电生理分析鉴定运动皮质内EGFP+神经元的CSMN身份。这条报告线提供了许多独特的优势;a)我们可以第一次可视化CSMN而不需要任何逆行标记手术;b)CSMN可以通过FACS介导的方法在生命的不同阶段得到纯化;c)可以详细和精确地研究导致CSMN脆弱性和退化的细胞和分子机制;d)最重要的是,这条新型报告线可以跨越到各种运动障碍的小鼠模型,以研究CSMN与疾病有关的生物学。在这项建议中,我们的目标是在各种运动神经元疾病的小鼠模型中为CSMN带来视觉清晰度。我们将把UCHL1-EGFP小鼠与最近发现的小鼠模型进行杂交,这些小鼠模型显示上运动神经元变性可能参与疾病病理。由于R21授予的时间限制,我们将在有限数量的小鼠模型中表征CSMN退化的时间和程度,例如Tdp43A315T和Alsin KO小鼠。我们生成的工具和我们开发的方法将有助于生成和表征其他报告小鼠模型,并将提高我们理解CSMN脆弱性和退化背后的细胞和分子机制的努力。
英文摘要
DESCRIPTION (provided by applicant): There are thousands of different neuron populations in our cerebral cortex, but in neurodegenerative diseases only a select neuron population show primary vulnerability and undergo progressive degeneration. Corticospinal motor neurons (CSMN) are large pyramidal neurons that are located in layer V of the motor cortex. Their cellular structure is very unique and they function as the "spokes person"of the cerebral cortex for the initiation and modulation of movement. Voluntary movement is the act of a clever and well-informed mind. Therefore CSMN receive information from numerous neurons, including long-distance projection and local circuitry neurons. CSMN's unique ability to integrate and translate this information into one signal towards spinal cord targets sets it apart from other cortical neurons. Therefore its degeneration has severe consequences that lead to various movement disorders. There is a developing need to understand the basis of CSMN degeneration in diseases. However, identification and visualization of CSMN is not easy as they are embedded among thousands of other neuron populations within the cerebral cortex. We recently generated a novel reporter line, the UCHL1-eGFP mice, in which CSMN are genetically labeled in the motor cortex. eGFP expression under the control of UCHL1 promoter is stable, persistent up to P800 in vivo, and is restricted to CSMN in the motor cortex. CSMN identity of eGFP+ neurons in the motor cortex are identified by anatomy, retrograde labeling, molecular marker expression profile and electrophysiological analysis. This reporter line offers many unique advantages; a) we can for the first time visualize CSMN without any need for a retrograde labeling surgery; b) CSMN can be purified by FACS- mediated approaches at different stages in life; c) the cellular and molecular mechanisms that are responsible for CSMN vulnerability and degeneration can be studied in detail and with precision; d) most importantly this novel reporter line can be crossed to various mouse models of movement disorders to investigate the biology of CSMN with respect to disease. In this proposal, our goal is to bring visual clarity to CSMN in various mouse models of motor neuron diseases. We will be crossing UCHL1-eGFP mice with the recently identified mouse models that show potential involvement of upper motor neuron degeneration in disease pathology. Due to time limitations of R21 grant, we will characterize the timing and extent of CSMN degeneration in a limited number of mouse models, such as the Tdp43A315T and Alsin KO mice. The tools we generate and the approach we develop will help generation and characterization of other reporter mouse models, and will improve our efforts of understanding the cellular and molecular mechanisms behind CSMN vulnerability and degeneration.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.drudis.2018.01.027
发表时间: 2018-03
期刊: Drug discovery today
影响因子: 7.4
作者: [Dervishi I, Ozdinler PH]
通讯作者: Ozdinler PH
DOI: 10.1093/hmg/ddv631
发表时间: 2016-03-15
期刊: Human molecular genetics
影响因子: 3.5
作者: [Gautam M, Jara JH, Sekerkova G, Yasvoina MV, Martina M, Özdinler PH]
通讯作者: Özdinler PH
Profiles of Common and Unique aspects of Upper Motor Neuron degeneration in HSP and ALS
  • 批准号:
    10526893
  • 项目类别:
  • 资助金额:
    $44.0万
  • 财政年份:
    2022
  • 负责人:
    Pembe Hande Ozdinler
  • 依托单位:
Novel Protein Aggregation Inhibitors and Upper Motor Neuron Stabilizers for ALS and other Neurodegenerative Diseases
  • 批准号:
    10624425
  • 项目类别:
  • 资助金额:
    $56.12万
  • 财政年份:
    2019
  • 负责人:
    Pembe Hande Ozdinler
  • 依托单位:
Administrative Supplement - Novel Protein Aggregation Inhibitors and Upper Motor Neuron Stabilizers for ALS and other Neurodegenerative Diseases
  • 批准号:
    10451057
  • 项目类别:
  • 资助金额:
    $12.0万
  • 财政年份:
    2019
  • 负责人:
    Pembe Hande Ozdinler
  • 依托单位:
Novel Protein Aggregation Inhibitors and Upper Motor Neuron Stabilizers for ALS and other Neurodegenerative Diseases
  • 批准号:
    10403947
  • 项目类别:
  • 资助金额:
    $60.96万
  • 财政年份:
    2019
  • 负责人:
    Pembe Hande Ozdinler
  • 依托单位:
海外基金